PROVAX

PHARMACEUTICAL COMPOSITIONS FOR USE IN IMMUNOTHERAPY COMPRISING ADJUVANT-ANTIGEN FORMULATIONS, NAMELY, PROPHYLACTIC AND THERAPEUTIC VACCINES FOR THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, AND INFECTIOUS DISEASES IN HUMANS